Adverum Biotechnologies Stock Investor Sentiment
| ADVM Stock | USD 3.00 0.23 7.12% |
About 61% of all Adverum Biotechnologies' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Adverum Biotechnologies suggests that some traders are interested. Adverum Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Adverum Biotechnologies. Many technical investors use Adverum Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 61
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Adverum Biotechnologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Adverum Biotechnologies.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Adverum Historical Sentiment
Although Adverum Biotechnologies' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Adverum, such as negative comments on social media and news outlets, may cause fear in the market and push Adverum Biotechnologies' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Adverum.
Adverum Biotechnologies Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Adverum Biotechnologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Adverum Biotechnologies Historical Investor Sentiment
Investor biases related to Adverum Biotechnologies' public news can be used to forecast risks associated with an investment in Adverum. The trend in average sentiment can be used to explain how an investor holding Adverum can time the market purely based on public headlines and social activities around Adverum Biotechnologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Adverum Biotechnologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adverum Biotechnologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Adverum Biotechnologies news discussions. The higher the estimate score, the more favorable the investor's outlook on Adverum Biotechnologies.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Adverum Biotechnologies' Stock prices. Below is the latest headlines and news related to Adverum Biotechnologies Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Adverum Biotechnologies that are available to investors today. This information is accessible both publicly - through Adverum Biotechnologies' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Adverum-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Adverum Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adverum Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adverum Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adverum Biotechnologies alpha.
Adverum Largest EPS Surprises
Earnings surprises can significantly impact Adverum Biotechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-11-08 | 2017-09-30 | -0.29 | -0.32 | -0.03 | 10 | ||
2020-05-28 | 2020-03-31 | -0.27 | -0.31 | -0.04 | 14 | ||
2019-05-08 | 2019-03-31 | -0.27 | -0.23 | 0.04 | 14 | ||
2019-03-06 | 2018-12-31 | -0.29 | -0.25 | 0.04 | 13 | ||
2018-11-08 | 2018-09-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2022-11-10 | 2022-09-30 | -0.34 | -0.4 | -0.06 | 17 |
There is far too much social signal, news, headlines, and media speculation about Adverum Biotechnologies that are available to investors today. This information is accessible both publicly - through Adverum Biotechnologies' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Adverum-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Adverum Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adverum Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adverum Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adverum Biotechnologies alpha.
Adverum Biotechnologies Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Svoronos Dawn of 40000 shares of Adverum Biotechnologies subject to Rule 16b-3 | 02/14/2025 |
2 | Acquisition by Leonard Braden Michael of 164886 shares of Adverum Biotechnologies at 4.0087 subject to Rule 16b-3 | 02/26/2025 |
3 | Acquisition by Leonard Braden Michael of 86802 shares of Adverum Biotechnologies at 4.4595 subject to Rule 16b-3 | 02/27/2025 |
4 | Acquisition by Laurent Fischer of 25000 shares of Adverum Biotechnologies subject to Rule 16b-3 | 02/28/2025 |
5 | Acquisition by Leonard Braden Michael of 18000 shares of Adverum Biotechnologies at 4.6 subject to Rule 16b-3 | 03/18/2025 |
6 | Acquisition by Leonard Braden Michael of 25000 shares of Adverum Biotechnologies at 4.9356 subject to Rule 16b-3 | 03/19/2025 |
7 | Acquisition by Leonard Braden Michael of 30600 shares of Adverum Biotechnologies at 5.6133 subject to Rule 16b-3 | 03/20/2025 |
8 | Acquisition by Laurent Fischer of 200000 shares of Adverum Biotechnologies at 7.15 subject to Rule 16b-3 | 03/21/2025 |
9 | ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm | 04/14/2025 |
10 | Adverum Biotechnologies GAAP EPS of -1.96 misses by 0.60 | 04/15/2025 |
11 | Adverum Biotechnologies Issues Earnings Results | 04/16/2025 |
12 | Chardan Capital Has Lowered Expectations for Adverum Biotechnologies Stock Price | 04/17/2025 |
13 | Acquisition by Leonard Braden Michael of 300000 shares of Adverum Biotechnologies at 3.0 subject to Rule 16b-3 | 04/22/2025 |
14 | Acquisition by Leonard Braden Michael of 50000 shares of Adverum Biotechnologies at 2.979 subject to Rule 16b-3 | 04/23/2025 |
15 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum ... | 04/25/2025 |
16 | Adverum Biotechnologies to Release Earnings on Thursday | 05/01/2025 |
17 | Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 05/02/2025 |
18 | 3 Penny Stocks Under 300M Market Cap To Consider | 05/06/2025 |
Check out Adverum Biotechnologies Hype Analysis, Adverum Biotechnologies Correlation and Adverum Biotechnologies Performance. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.62) | Revenue Per Share | Quarterly Revenue Growth (0.70) | Return On Assets | Return On Equity |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.